David A. Karnofsky
David A. Karnofsky | |
|---|---|
| Born | March 28, 1914 |
| Died | August 31, 1969 |
| Nationality | American |
| Alma mater | Harvard Medical School |
| Known for | Karnofsky Performance Status Scale |
| Scientific career | |
| Fields | Oncology |
| Institutions | Memorial Sloan Kettering Cancer Center |
David A. Karnofsky (March 28, 1914 – August 31, 1969) was an American oncologist renowned for his contributions to the field of cancer treatment and chemotherapy. He is best known for developing the Karnofsky Performance Status Scale, a standard way of measuring the ability of cancer patients to perform ordinary tasks.
Early Life and Education[edit | edit source]
David A. Karnofsky was born on March 28, 1914, in the United States. He pursued his medical education at Harvard Medical School, where he developed an interest in oncology.
Career[edit | edit source]
Karnofsky's career was primarily associated with the Memorial Sloan Kettering Cancer Center, where he made significant advancements in the treatment of cancer. His work in chemotherapy helped to establish protocols that are still in use today.
Karnofsky Performance Status Scale[edit | edit source]
The Karnofsky Performance Status Scale is one of Karnofsky's most notable contributions. This scale is used to assess the functional status of a patient and helps in determining their prognosis and appropriate treatment options. It ranges from 0 to 100, with higher scores indicating better functional status.
Legacy[edit | edit source]
David A. Karnofsky's work has had a lasting impact on the field of oncology. The Karnofsky Performance Status Scale remains a critical tool in both clinical practice and research. His contributions have paved the way for advancements in cancer treatment and patient care.
Death[edit | edit source]
David A. Karnofsky passed away on August 31, 1969. His legacy continues to influence the field of oncology and the treatment of cancer patients.
See Also[edit | edit source]
- Oncology
- Chemotherapy
- Memorial Sloan Kettering Cancer Center
- Harvard Medical School
- Karnofsky Performance Status Scale
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
